Clinical trials
Thyroid Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 5 |
| University Medical Center Groningen | 4 |
| Exelixis | 3 |
| Bayer | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Genzyme, a Sanofi Company | 2 |
| Leiden University Medical Center | 2 |
| Genmab | 1 |
| Hoffmann-La Roche | 1 |
| Kura Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 26 |
| Carcinoma, Medullary | 10 |
| Head and Neck Neoplasms | 5 |
| Thyroid Cancer, Papillary | 5 |
| Adenocarcinoma, Follicular | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colonic Neoplasms | 3 |
| Thyroid Carcinoma, Anaplastic | 3 |
| Adenocarcinoma | 2 |
| Bronchial Neoplasms | 2 |
Trials
Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.